Arcadia Biosciences
RKDA
16 hedge funds and large institutions have $227K invested in Arcadia Biosciences in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
14% more funds holding
Funds holding: 14 → 16 (+2)
0.46% more ownership
Funds ownership: 4.33% → 4.79% (+0.46%)
12% less capital invested
Capital invested by funds: $259K → $227K (-$32K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$41K |
| 2 |
Citigroup
New York
|
+$1.46K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$842 |
| 4 |
PP
PFS Partners
Mine Hill,
New Jersey
|
+$20 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$9.14K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.9K |
| 3 |
AWM
Atticus Wealth Management
Palm Beach Gardens,
Florida
|
-$1.17K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$932 |
| 5 |
Morgan Stanley
New York
|
-$731 |
RKDA Hedge Fund Activity: Q3 2025 in Review
16 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q3 2025, worth a combined $227K — down 12% from $259K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RKDA positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 5 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $41K. The largest seller was Mariner, cutting an estimated $9.14K.
- 16 institutional investors held Arcadia Biosciences (RKDA) as of Q3 2025, up from 14 in Q2 2025.
- Funds reported $227K of Arcadia Biosciences stock for Q3 2025, down 12% quarter-over-quarter.
- 3 funds opened new Arcadia Biosciences positions in Q3 2025 and 1 closed out, a net change of +2 holders.
- The largest Arcadia Biosciences buyer in Q3 2025 was DRW Securities, an estimated $41K added.
- The largest Arcadia Biosciences seller in Q3 2025 was Mariner, an estimated $9.14K sold.
Based on aggregated 13F filings for Q3 2025.